<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VRQABMZP</identifier><date>2017</date><creator>Morgan, Tina</creator><relation>documents/doc/V/URN_NBN_SI_doc-VRQABMZP_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VRQABMZP_001.txt</relation><format format_type="issue">2</format><format format_type="volume">68</format><format format_type="type">article</format><format format_type="extent">str. 167-172</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">30985767</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VRQABMZP</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">prikaz primera</subject><subject language_type_id="slv">srčno popuščanje</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><subject language_type_id="slv">zdravljenje z zdravili</subject><title>Vloga in pričakovani učinki zdravil pri srčnem popuščanju s prikazom primera</title></Record>